NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ANGO

Angiodynamic Inc

Jun 30 • 04:00PM ET

9.92

Dollar change +0.14
Percentage change 1.43	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: JNJ SYK MDT BSX EW ABT BAX ZBH HOLX XRAY

| Held by: VTI IWM VXF IWN VTWO SCHA VHT VFMO DFAS DFAT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.02	Insider Own	4.63%	Shs Outstand	40.97M	Perf Week	-0.70%
Market Cap	402.83M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-0.22%	Shs Float	38.73M	Perf Month	-0.80%
Enterprise Value	362.47M	PEG	-	EPS next Q	-0.12	Inst Own	89.56%	Short Float	6.56%	Perf Quarter	4.42%
Income	-41.39M	P/S	1.42	EPS this Y	27.09%	Inst Trans	11.25%	Short Ratio	4.43	Perf Half Y	14.15%
Sales	283.32M	P/B	2.19	EPS next Y	18.70%	ROA	-13.57%	Short Interest	2.54M	Perf YTD	8.30%
Book/sh	4.54	P/C	9.00	EPS next 5Y	-	ROE	-20.46%	52W High	13.50 -26.52%	Perf Year	72.22%
Cash/sh	1.10	P/FCF	-	EPS past 3/5Y	-77.33% -	ROIC	-21.97%	52W Low	5.47 81.35%	Perf 3Y	-50.77%
Dividend Est.	-	EV/EBITDA	659.03	Sales past 3/5Y	1.46% 2.35%	Gross Margin	50.72%	Volatility	3.27% 5.02%	Perf 5Y	-3.22%
Dividend TTM	-	EV/Sales	1.28	EPS Y/Y TTM	-188.57%	Oper. Margin	-9.26%	ATR (14)	0.45	Perf 10Y	-40.56%
Dividend Ex-Date	-	Quick Ratio	1.40	Sales Y/Y TTM	-12.56%	Profit Margin	-14.61%	RSI (14)	45.50	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.21	EPS Q/Q	97.69%	SMA20	-5.27%	Beta	0.60	Target Price	15.67
Payout	-	Debt/Eq	0.02	Sales Q/Q	-4.23%	SMA50	0.75%	Rel Volume	0.58	Prev Close	9.78
Employees	748	LT Debt/Eq	0.01	Earnings	Apr 02 BMO	SMA200	9.37%	Avg Volume	573.06K	Price	9.92
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.46% 2.43%	Trades		Volume	331,502	Change	1.43%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-05-24	Upgrade	Oppenheimer	Perform → Outperform	$12
Sep-25-23	Initiated	H.C. Wainwright	Buy	$19
Apr-17-23	Downgrade	Raymond James	Strong Buy → Outperform	$14 → $13
Oct-15-21	Upgrade	Canaccord Genuity	Hold → Buy	$28 → $37
Aug-20-21	Initiated	Oppenheimer	Perform
Nov-25-20	Upgrade	Raymond James	Mkt Perform → Strong Buy	$18
Apr-08-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-01-19	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-03-18	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-05-18	Downgrade	Craig Hallum	Buy → Hold
Apr-07-17	Reiterated	Cantor Fitzgerald	Overweight	$20 → $21
Mar-30-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Feb-08-17	Initiated	Barclays	Equal Weight	$17
Nov-04-16	Initiated	Cantor Fitzgerald	Buy
Apr-08-16	Resumed	Piper Jaffray	Neutral
Jan-08-16	Reiterated	Canaccord Genuity	Buy	$17.50 → $14.50
Nov-10-15	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-24-15	Initiated	KeyBanc Capital Mkts	Overweight
Jun-19-14	Upgrade	Canaccord Genuity	Hold → Buy	$16.25 → $20
Oct-09-12	Reiterated	Canaccord Genuity	Hold	$14 → $13.50

Show Previous Ratings

Jun-26-25 10:55AM	SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System (Zacks)
08:23AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
Jun-24-25 10:43AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
Jun-23-25 08:00AM	AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism (Business Wire)
Jun-20-25 11:40AM	Smith+Nephew Stock May Gain From Strategic Deal With Standard Health (Zacks)
11:36AM	Loading…
11:36AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
Jun-18-25 09:55AM	GE HealthCare Stock Slips Despite the Launch of bkActiv S Series (Zacks)
09:52AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
Jun-17-25 11:39AM	VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma (Zacks) -6.01%
Jun-16-25 11:14AM	INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach (Zacks)
Jun-13-25 12:37PM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
Jun-11-25 10:28AM	Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now (Zacks)
Jun-09-25 11:55AM	ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite (Zacks)
11:35AM	Zacks Industry Outlook Penumbra, Integer and AngioDynamics (Zacks)
Jun-06-25 12:26PM	NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial (Zacks)
09:41AM	Loading…
09:41AM	3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom (Zacks)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 12:31PM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
12:26PM	HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
12:00PM	What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now? (Zacks)
Jun-03-25 12:10PM	Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System (Zacks) +12.89%
Jun-02-25 08:38AM	Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit (Zacks)
May-30-25 10:14AM	BD Stock Might See Short-term Decline After Warning on Tamponade Tubes (Zacks)
09:40AM	Are Medical Stocks Lagging AngioDynamics (ANGO) This Year? (Zacks)
May-29-25 10:08AM	Here's Why You Should Add HealthEquity Stock to Your Portfolio Now (Zacks)
10:06AM	VEEV Stock Up as Q1 Earnings & Revenues Beat Estimates, Margin Rise (Zacks)
09:31AM	Alcon Stock Rises Following the FDA Approval of TRYPTYR (Zacks)
May-28-25 11:50AM	NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial (Zacks) +5.66%
11:47AM	Reasons to Retain Veeva Systems Stock in Your Portfolio for Now (Zacks)
09:22AM	Abbott Stock Gains Following FDA Approval of the Tendyne System (Zacks)
12:42PM	Loading…
May-26-25 12:42PM	BioSig Stock Surges Following Share Exchange Deal With Streamex (Zacks)
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
10:36AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
08:41AM	QGEN Stock Might Gain Following New Partnership With ID Solutions (Zacks)
06:52AM	Is it Worth Retaining ResMed Stock in Your Portfolio Now? (Zacks)
May-22-25 11:39AM	AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech (Zacks)
08:26AM	Walgreens Opens New Micro-Fulfillment Center in Brooklyn Park (Zacks)
May-21-25 10:48AM	BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad (Zacks)
09:44AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
09:10AM	Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market (Zacks)
07:21AM	Is it the Right Time to Hold STERIS Stock in Your Portfolio? (Zacks)
May-20-25 09:22AM	SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System (Zacks)
07:53AM	Neogen Stock Gains Following Strategic Alliance With Syngenta (Zacks)
May-19-25 10:12AM	BD Stock May Rise Following the Launch of FACSDiscover A8 Platform (Zacks)
May-16-25 10:22AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
10:12AM	GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL (Zacks)
07:59AM	ALGN Stock Might Rise Following the NMPA Approval in China (Zacks)
May-15-25 08:40AM	STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket (Zacks)
May-14-25 09:40AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? (Zacks)
08:49AM	Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered (Zacks)
May-13-25 09:41AM	Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase (Zacks)
07:07AM	QIAGEN Stock Gains Following the Acquisition of Genoox (Zacks)
May-12-25 09:10AM	Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised (Zacks) +5.05%
08:40AM	HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up (Zacks)
07:24AM	GMED Q1 Earnings & Revenues Miss, '25 EPS View Down, Stock Falls (Zacks)
May-09-25 01:29PM	Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up (Zacks)
08:49AM	Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips (Zacks)
May-08-25 08:13AM	Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised (Zacks) +5.82%
08:09AM	Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash (Zacks)
07:54AM	EYE Q1 Earnings and Revenues Beat, Gross Margin Up, Stock Surges (Zacks)
06:52AM	QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up (Zacks)
May-07-25 10:05AM	Bio-Techne Q3 Earnings & Revenues Top Estimates, Stock Up in Premarket (Zacks)
09:35AM	CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up (Zacks)
09:20AM	Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up (Zacks)
08:34AM	MYGN Q1 Earnings Top Estimates, Stock Down on Weak 2025 Outlook (Zacks)
May-06-25 09:04AM	Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut (Zacks)
07:10AM	NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash (Zacks)
May-05-25 12:59PM	ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket (Zacks)
08:46AM	Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls (Zacks)
07:24AM	Teleflex Q1 Earnings Beat, '25 EPS View Down, Stock Up (Zacks)
May-02-25 11:30AM	AngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound? (Zacks)
08:03AM	TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up (Zacks)
07:58AM	BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket (Zacks)
07:28AM	EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised (Zacks)
07:25AM	Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down (Zacks)
May-01-25 09:49AM	IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market (Zacks)
09:16AM	ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down (Zacks)
09:15AM	CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up (Zacks)
08:23AM	ALGN Q1 Earnings and Revenues Top Estimates, Stock Up in After-market (Zacks)
Apr-29-25 08:53AM	Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains (Zacks)
Apr-28-25 09:55AM	Wall Street Analysts See a 63.23% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High? (Zacks)
09:40AM	Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-25-25 10:18AM	CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Apr-24-25 10:42AM	Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand (Zacks)
07:25AM	AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise (Zacks)
07:24AM	ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market (Zacks)
06:43AM	EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised (Zacks)
Apr-23-25 12:53PM	Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up (Zacks)
09:47AM	BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised (Zacks)
Apr-22-25 11:34AM	Concentra Stock Slips Despite Deal to Acquire Pivot Onsite Innovations (Zacks)
10:34AM	Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up (Zacks)
Apr-21-25 11:08AM	ECL Stock Gains Following 5% Trade Surcharge in the United States (Zacks)
Apr-16-25 01:07PM	Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market (Zacks)
10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
09:21AM	Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now (Zacks)
07:13AM	LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 (Zacks)
07:10AM	Here's Why You Should Retain Inogen Stock in Your Portfolio Now (Zacks)
Apr-15-25 11:20AM	HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold? (Zacks)
11:04AM	Merit Medical Stock Slips Despite the Launch of New Ventrax System (Zacks)
Apr-14-25 09:39AM	Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler (Zacks) +5.38%

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nighan Warren JR	SVP Quality and Regulatory	Jan 16 '25	Sale	12.31	4,060	49,979	41,817	Jan 17 04:05 PM
Nighan Warren JR	Officer	Jan 16 '25	Proposed Sale	12.31	4,060	49,979		Jan 16 04:05 PM
Nighan Warren JR	SVP Quality and Regulatory	Oct 07 '24	Buy	6.09	768	4,677	45,777	Oct 10 03:22 PM
Nighan Warren JR	SVP Quality and Regulatory	Oct 10 '24	Buy	6.08	100	608	45,877	Oct 10 03:22 PM
Trowbridge Stephen A	EVP and CFO	Oct 08 '24	Buy	5.86	1,700	9,962	172,711	Oct 08 06:27 PM
Clemmer James C	President and CEO	Oct 07 '24	Buy	6.03	20,000	120,600	681,582	Oct 08 04:32 PM
Piccinini Laura	SVP International	Jul 17 '24	Option Exercise	0.00	4,439	0	42,491	Aug 02 09:55 PM
Clemmer James C	President and CEO	Jul 17 '24	Option Exercise	0.00	56,279	0	690,312	Aug 02 09:53 PM
Nighan Warren JR	SVP Quality and Regulatory	Jul 17 '24	Option Exercise	0.00	5,677	0	46,675	Aug 02 09:50 PM
Campbell Chad Thomas	SVP/GM, Vascular Access	Jul 17 '24	Option Exercise	0.00	6,600	0	70,187	Aug 02 09:48 PM
Trowbridge Stephen A	EVP and CFO	Jul 17 '24	Option Exercise	0.00	11,142	0	177,612	Aug 02 09:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANGO

Angiodynamic Inc

Upgrade your FINVIZ experience